Melanoma is the fifth most common cancer in the UK1


Every year there are 16,700 new melanoma skin cancer cases in the UK, equivalent to around 46 cases every day1


Skin cancer is the most common cancer in the UK.2 It is comprised of malignant melanoma and non-melanoma. Malignant melanoma originates from melanocytes and can be fatal if not diagnosed and treated early.2,3 The more common non-melanoma originates from either squamous or basal cell carcinomas and is rarely fatal if treated early.2,3

It is important to diagnose melanoma as early as possible to ensure early treatment and improved patient outcomes.4 Cases of melanoma continue to rise with an increase in incidence of 140% since the early 1990s.1

To find out more about melanoma and its diagnosis and treatment, please select an option below.


  1. Cancer Research UK. Incidence of melanoma in the UK. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s.... [Accessed June 2022].
  2. National Cancer Registration and Analysis Services. Available at: http://www.ncin.org.uk/cancer_type_and_topic_specific_work/cancer_type_s.... [Accessed June 2022].
  3. American Cancer Society. What is melanoma skin cancer? Available at: https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanom... [Accessed June 2022].
  4. Davis LE, et al. Cancer Biol Ther 2019;20:1366–1379.



Rate this content: 
No votes yet
UK | July 2022 | 226129

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]